Given that EGR1 has been implicated in the pathological changes in AD and can be modulated by SET1/MLL and SETDB1 (ESET) through the methylation pathway, we hypothesize that the two histone methyltransferases may also influence the pathological progression of AD by affecting EGR1. This evidence concerns the gene PRDM9 and Alzheimer disease.